Literature DB >> 32981600

Lung Cancer in People's Republic of China.

Shugeng Gao1, Ning Li2, Shuhang Wang2, Fan Zhang1, Wenqiang Wei3, Ni Li4, Nan Bi5, Zhijie Wang6, Jie He7.   

Abstract

Entities:  

Year:  2020        PMID： 32981600     DOI： 10.1016/j.jtho.2020.04.028

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  36 in total

1.  Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.

Authors:  Xiaoli Zhuo; Honglin Guo; Jun Ma; Jingjiang Lai; Lei Liu; Ke Yin; Jing Zhao; Jingliang Wang; Fengxian Jiang; Wei Xu; Xiaotian Yuan; Xiaoyan Lin; Guobin Fu
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-13       Impact factor: 4.322

2.  Sufentanil inhibits the proliferation and epithelial mesenchymal transition of lung cancer cells through Wnt/beta-catenin signaling pathway.

Authors:  Minghan Guan; Yifeng Huang; Xiaowen Lin
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Relationship Between Post-traumatic Stress Symptoms and Anticipatory Grief in Family Caregivers of Patients With Advanced Lung Cancer: The Mediation Role of Illness Uncertainty.

Authors:  Di Sun; Zhihui Mao; Xu Zhang; Jiaojiao Li; Lijuan Zhang
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

4.  Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancer.

Authors:  Yanfeng Wang; Chanjuan Cui; Xin Liu; Lei Deng; Ke Yang; Bin Li; Jie Xue; Junying Xie; Wei Cui
Journal:  Thorac Cancer       Date:  2022-05-13       Impact factor: 3.223

5.  Age at first birth and lung cancer: a two-sample Mendelian randomization study.

Authors:  Haoxin Peng; Xiangrong Wu; Yaokai Wen; Xiaoqin Du; Caichen Li; Hengrui Liang; Jinsheng Lin; Jun Liu; Fan Ge; Zhenyu Huo; Jianxing He; Wenhua Liang
Journal:  Transl Lung Cancer Res       Date:  2021-04

6.  Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.

Authors:  Xiaohan Dong; Minghui Chang; Xingguo Song; Shanshan Ding; Li Xie; Xianrang Song
Journal:  Thorac Cancer       Date:  2020-12-28       Impact factor: 3.500

7.  Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.

Authors:  Jieke Liu; Hao Xu; Haomiao Qing; Yong Li; Xi Yang; Changjiu He; Jing Ren; Peng Zhou
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

8.  Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma.

Authors:  Yu Tian; Peiwei Li; Zhaohua Xiao; Jie Zhou; Xia Xue; Ning Jiang; Chuanliang Peng; Licun Wu; Hui Tian; Helmut Popper; Mau-Ern Poh; Fabrizio Marcucci; Chengke Zhang; Xiaogang Zhao
Journal:  Transl Lung Cancer Res       Date:  2021-02

9.  Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel.

Authors:  Qiong Lu; Zhongwei Jia; Junli Gao; Meijuan Zheng; Junshun Gao; Mingjie Tong; Jinxing Xia; Fang Li; Baoling Yang; Lili Zhang; Bo Wang; Rui Wang; Jinping Qiao; Qinqin Lou; Jinbo Gao; Yuanhong Xu
Journal:  J Cancer       Date:  2021-03-15       Impact factor: 4.207

10.  Efficacy and safety of bevacizumab combined with EGFR-TKIs in advanced non-small cell lung cancer: A meta-analysis.

Authors:  Yifan Yang; Liming Wang; Xu Li; Shuai Zhang; Jiangyong Yu; Xin Nie; Wenbo Liu; Xiaonan Wu; Ping Zhang; Yi Li; Ailing Li; Bin Ai
Journal:  Thorac Cancer       Date:  2021-12-03       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.